Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Our Entrepreneurs

We are proud to have been the capital partner to some of the most talented medtech teams in our industry. Our entrepreneurs have pioneered new treatments for chronic diseases, built entirely new commercial markets from the ground up, and ushered in the future of personalized medicine and connected care.

Acquired by Boston Scientific

Acquired by Edwards Lifesciences

Acquired by Wright Medical

Acquired by Smith & Nephew

Acquired by Alcon

Acquired by Covidien

IPO (NASDAQ: CVRX)

Acquired by Medtronic

IPO (NASDAQ: NARI)

Acquired by Philips

Acquired by CR Bard

Acquired by Johnson & Johnson

Acquired by Labcorp

Acquired by Zoll Medical

IPO (NYSE American: SENS)

Acquired by Terumo

Acquired by Abbott

Acquired by Merz

Acquired by Olympus

Acquired by Boston Scientific

Acquired by Philips

Acquired by Johnson & Johnson

Acquired by RTI Surgical

19

Novel FDA PMA & de novo 510k approvals

45

U.S. Commercial Product Launches

34

Level I Clinical Trials

26

Strategic Financings

28

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS℠

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
Moxe Health Raises $30M Series B to Further Advance Interoperability
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics
Apella Announces $21 Million Series A Funding to Digitize the Operating Room
Resources
News LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2022 Vensana Capital Management, LLC | Privacy | Terms & Conditions